Your browser doesn't support javascript.
loading
Outcome of 177 Lu-PSMA Radionuclide Treatment in Advanced Prostate Cancer and Its Association With Clinical Parameters : A Single-Center Experience.
Has Simsek, Duygu; Kuyumcu, Serkan; Karadogan, Seyfullah; Ozkan, Zeynep Gozde; Isik, Emine Goknur; Basaran, Mert; Sanli, Mehmet Oner; Sanli, Yasemin.
Afiliação
  • Has Simsek D; From the Department of Nuclear Medicine, Istanbul Faculty of Medicine.
  • Kuyumcu S; From the Department of Nuclear Medicine, Istanbul Faculty of Medicine.
  • Karadogan S; From the Department of Nuclear Medicine, Istanbul Faculty of Medicine.
  • Ozkan ZG; From the Department of Nuclear Medicine, Istanbul Faculty of Medicine.
  • Isik EG; From the Department of Nuclear Medicine, Istanbul Faculty of Medicine.
  • Basaran M; Department of Medical Oncology, Institute of Oncology.
  • Sanli MO; Department of Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Sanli Y; From the Department of Nuclear Medicine, Istanbul Faculty of Medicine.
Clin Nucl Med ; 47(8): e521-e528, 2022 Aug 01.
Article em En | MEDLINE | ID: mdl-35543629

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article